Balance Sheet CVS Health Corporation

Equities

CVS

US1266501006

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 12/05/2026 am IST			After hours 02:26:32 am
92.22 ^USD	+1.84%		92.04	-0.19%

04:53pm	TD Cowen Adjusts Price Target on CVS Health to $110 From $105	MT
07/05	CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says	MT

c7c21ce4cb54db68a7955e31ce49.W_b75VIcQXzLK8sZ9ZCqvZByov9NLh5TIcQbXxnp1gg.NsO-12BbIheiX69Ul73B7aUFlaw1YFwpfoVcO0HEkT06so-WYXIMN6Vhkg

Published financial data: CVS HEALTH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	29TCr	32TCr	36TCr	37TCr	40TCr
Total Revenues	29TCr	32TCr	36TCr	37TCr	40TCr
Cost of Goods Sold, Total	24TCr	27TCr	30TCr	32TCr	35TCr
Gross Profit	5.08TCr	5.35TCr	5.33TCr	4.92TCr	5.31TCr
Selling General & Admin Expenses, Total	3.71TCr	3.8TCr	3.92TCr	4.12TCr	4.31TCr
Other Operating Expenses, Total	3.71TCr	3.8TCr	3.92TCr	4.12TCr	4.31TCr
Operating Income	1.38TCr	1.54TCr	1.41TCr	801.9Cr	1TCr
Interest Expense, Total	-250.3Cr	-228.7Cr	-265.8Cr	-295.8Cr	-311.9Cr
Interest And Investment Income	119.9Cr	84Cr	115.3Cr	215.3Cr	223.3Cr
Net Interest Expenses	-130.4Cr	-144.9Cr	-150.5Cr	-80Cr	-89Cr
Other Non Operating Income (Expenses)	-40L	-40L	-60L	-50L	-50L
EBT, Excl. Unusual Items	1.25TCr	1.4TCr	1.26TCr	720.9Cr	912.8Cr
Restructuring Charges	-135.8Cr	-	-55Cr	-120.9Cr	-9.3Cr
Merger & Related Restructuring Charges	-13Cr	-	-49Cr	-24Cr	-12Cr
Impairment of Goodwill	-43Cr	-	-	-	-572.5Cr
Gain (Loss) On Sale Of Assets	-	-253.3Cr	-35Cr	-	48Cr
Asset Writedown	-	-	-	-	-
Legal Settlements	26Cr	-580.3Cr	-	-10Cr	-154Cr
Other Unusual Items	-39Cr	-	-	49Cr	-
EBT, Incl. Unusual Items	1.04TCr	562.8Cr	1.12TCr	614.8Cr	213.6Cr
Income Tax Expense	252.2Cr	146.3Cr	280.5Cr	156.2Cr	41Cr
Earnings From Continuing Operations	789.8Cr	416.5Cr	836.8Cr	458.6Cr	172.8Cr
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	789.8Cr	416.5Cr	836.8Cr	458.6Cr	172.8Cr
Minority Interest	1.2Cr	-1.6Cr	-2.4Cr	2.8Cr	4Cr
Net Income - (IS)	791Cr	414.9Cr	834.4Cr	461.4Cr	176.8Cr
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	791Cr	414.9Cr	834.4Cr	461.4Cr	176.8Cr
Net Income to Common Excl. Extra Items	791Cr	414.9Cr	834.4Cr	461.4Cr	176.8Cr
Per Share Items
Net EPS - Basic	6	3.16	6.49	3.66	1.4
Basic EPS - Continuing Operations	6	3.16	6.49	3.66	1.4
Basic Weighted Average Shares Outstanding	131.9Cr	131.2Cr	128.5Cr	125.9Cr	126.7Cr
Net EPS - Diluted	5.95	3.14	6.47	3.66	1.39
Diluted EPS - Continuing Operations	5.95	3.14	6.47	3.66	1.39
Diluted Weighted Average Shares Outstanding	132.9Cr	132.3Cr	129Cr	126.2Cr	127.1Cr
Normalized Basic EPS	5.92	6.64	6.09	3.6	4.53
Normalized Diluted EPS	5.87	6.58	6.07	3.59	4.52
Dividend Per Share	2	2.2	2.42	2.66	2.66
Payout Ratio	33.19	70.06	37.54	73.1	192.14
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1.83TCr	1.97TCr	1.84TCr	1.26TCr	1.46TCr
EBITA	1.6TCr	1.72TCr	1.6TCr	1TCr	1.2TCr
EBIT	1.38TCr	1.54TCr	1.41TCr	801.9Cr	1TCr
EBITDAR	2.15TCr	2.28TCr	2.16TCr	1.56TCr	1.76TCr
Total Revenues (As Reported)	29TCr	32TCr	36TCr	37TCr	40TCr
Effective Tax Rate - (Ratio)	24.2	26	25.11	25.41	19.1
Current Domestic Taxes	295Cr	353.8Cr	348.1Cr	213.4Cr	19Cr
Current Foreign Taxes	-	-	-	-	11Cr
Total Current Taxes	295Cr	353.8Cr	348.1Cr	213.4Cr	31Cr
Deferred Domestic Taxes	-43Cr	-207.5Cr	-68Cr	-57Cr	10Cr
Total Deferred Taxes	-43Cr	-207.5Cr	-68Cr	-57Cr	10Cr
Normalized Net Income	780.51Cr	871.15Cr	782.72Cr	453.36Cr	574.5Cr
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	253.7Cr	228.7Cr	7.3Cr	7.1Cr	6.9Cr
Non-Cash Pension Expense	-19Cr	-17Cr	-9.4Cr	-10Cr	-12Cr
Supplemental Operating Expense Items
Advertising Expense	52Cr	74Cr	98Cr	99Cr	97Cr
Selling and Marketing Expenses	52Cr	74Cr	98Cr	99Cr	97Cr
Net Rental Expense, Total	320.7Cr	315.5Cr	312.6Cr	302.4Cr	301.6Cr
Imputed Operating Lease Interest Expense	80Cr	79Cr	89Cr	88Cr	92Cr
Imputed Operating Lease Depreciation	240.95Cr	236.82Cr	224.04Cr	214.22Cr	209.19Cr
Stock-Based Comp., Other (Total)	48Cr	45Cr	59Cr	54Cr	54Cr
Total Stock-Based Compensation	48Cr	45Cr	59Cr	54Cr	54Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	940.8Cr	1.29TCr	819.6Cr	858.6Cr	845.3Cr
Short Term Investments	311.7Cr	277.8Cr	325.9Cr	240.7Cr	214.5Cr
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	1.25TCr	1.57TCr	1.15TCr	1.1TCr	1.06TCr
Accounts Receivable, Total	2.1TCr	2.38TCr	1.56TCr	1.46TCr	1.63TCr
Other Receivables	338.9Cr	344.9Cr	1.96TCr	2.19TCr	2.35TCr
Total Receivables	2.44TCr	2.73TCr	3.52TCr	3.65TCr	3.98TCr
Inventory	1.78TCr	1.91TCr	1.8TCr	1.81TCr	1.92TCr
Restricted Cash	306.5Cr	14Cr	9Cr	9.5Cr	5.9Cr
Other Current Assets, Total	222.7Cr	344.9Cr	306.1Cr	298.1Cr	503.2Cr
Total Current Assets	6TCr	6.57TCr	6.79TCr	6.86TCr	7.47TCr
Gross Property Plant And Equipment	5.27TCr	5.22TCr	5.11TCr	5.24TCr	5.28TCr
Accumulated Depreciation	-2.07TCr	-2.15TCr	-2.07TCr	-2.34TCr	-2.47TCr
Net Property Plant And Equipment	3.2TCr	3.07TCr	3.04TCr	2.89TCr	2.81TCr
Long-term Investments	2.3TCr	2.11TCr	2.3TCr	2.89TCr	3.27TCr
Goodwill	7.91TCr	7.82TCr	9.13TCr	9.13TCr	8.55TCr
Other Intangibles, Total	2.9TCr	2.48TCr	2.92TCr	2.73TCr	2.55TCr
Other Long-Term Assets, Total	980.1Cr	784.8Cr	791Cr	810.4Cr	711.3Cr
Total Assets	23TCr	23TCr	25TCr	25TCr	25TCr
Liabilities
Accounts Payable, Total	1.25TCr	1.48TCr	1.49TCr	1.59TCr	1.76TCr
Accrued Expenses, Total	2.53TCr	2.91TCr	3.39TCr	3.57TCr	3.77TCr
Short-term Borrowings	-	-	20Cr	211.9Cr	-
Current Portion of Long-Term Debt	415.5Cr	171.9Cr	270.6Cr	355.9Cr	400.7Cr
Current Portion of Leases	169.6Cr	173.7Cr	180.7Cr	181.6Cr	179.8Cr
Unearned Revenue Current, Total	8.7Cr	7.1Cr	15Cr	14Cr	6.2Cr
Other Current Liabilities	2.4TCr	2.23TCr	2.55TCr	2.53TCr	2.75TCr
Total Current Liabilities	6.78TCr	6.97TCr	7.92TCr	8.46TCr	8.87TCr
Long-Term Debt	5.07TCr	4.91TCr	5.73TCr	5.92TCr	5.92TCr
Long-Term Leases	1.94TCr	1.82TCr	1.74TCr	1.62TCr	1.49TCr
Pension & Other Post Retirement Benefits	25Cr	20Cr	19Cr	17Cr	16Cr
Deferred Tax Liability Non Current	627Cr	388Cr	431.1Cr	380.6Cr	383.2Cr
Other Non Current Liabilities	1.31TCr	1.59TCr	1.47TCr	1.35TCr	1.13TCr
Total Liabilities	16TCr	16TCr	17TCr	18TCr	18TCr
Common Stock, Total	1.7Cr	1.8Cr	1.8Cr	1.8Cr	1.8Cr
Additional Paid In Capital	4.74TCr	4.82TCr	4.9TCr	4.96TCr	5.04TCr
Retained Earnings	5.49TCr	5.61TCr	6.16TCr	6.28TCr	6.12TCr
Treasury Stock	-2.81TCr	-3.18TCr	-3.38TCr	-3.68TCr	-3.68TCr
Comprehensive Income and Other	94Cr	-149.4Cr	-33Cr	-12Cr	41Cr
Total Common Equity	7.51TCr	7.1TCr	7.65TCr	7.56TCr	7.52TCr
Minority Interest	31Cr	30Cr	18Cr	17Cr	17Cr
Total Equity	7.54TCr	7.13TCr	7.66TCr	7.57TCr	7.54TCr
Total Liabilities And Equity	23TCr	23TCr	25TCr	25TCr	25TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	131.25Cr	128.41Cr	125.84Cr	126.08Cr	127.22Cr
ECS Total Common Shares Outstanding	132.2Cr	130Cr	128.8Cr	126Cr	127.1Cr
Book Value / Share	56.79	54.63	59.36	59.97	59.18
Tangible Book Value	-3.31TCr	-3.19TCr	-4.4TCr	-4.3TCr	-3.58TCr
Tangible Book Value Per Share	-25.02	-24.53	-34.2	-34.15	-28.14
Total Debt	7.6TCr	7.07TCr	7.94TCr	8.29TCr	8TCr
Net Debt	6.35TCr	5.5TCr	6.79TCr	7.19TCr	6.94TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-67Cr	-61Cr	-64Cr	-84Cr	-95Cr
Debt Equivalent Oper. Leases	2.57TCr	2.52TCr	2.5TCr	2.42TCr	2.41TCr
Minority Interest, Total (Incl. Fin. Div)	31Cr	30Cr	18Cr	17Cr	17Cr
Account Code - Inventory Valuation	6	6	6	6	6
Land - (BS)	203.8Cr	199.6Cr	195.8Cr	184.7Cr	180.9Cr
Buildings, Total	422.5Cr	454.5Cr	457.1Cr	463.2Cr	459.3Cr
Machinery, Total	1.36TCr	1.27TCr	1.1TCr	1.17TCr	1.17TCr
Full Time Employees	2L	2L	2L	2L	2L
Part Time Employees	84T	81T	81T	81T	81T
Accumulated Allowance for Doubtful Accounts (Supple)	34Cr	33Cr	34Cr	41Cr	18Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	791Cr	414.9Cr	834.4Cr	461.4Cr	176.8Cr
Depreciation & Amortization - CF	225.3Cr	243.9Cr	246.1Cr	257.2Cr	263Cr
Amortization of Goodwill and Intangible Assets - (CF)	225.9Cr	180.8Cr	190.5Cr	202.5Cr	197.6Cr
Depreciation & Amortization, Total	451.2Cr	424.7Cr	436.6Cr	459.7Cr	460.6Cr
(Gain) Loss From Sale Of Asset	-	205.8Cr	35Cr	-	-25Cr
Asset Writedown & Restructuring Costs	178.9Cr	-	-	84Cr	572.5Cr
Stock-Based Compensation (CF)	48Cr	45Cr	59Cr	54Cr	54Cr
Other Operating Activities, Total	-38Cr	-172.7Cr	-24Cr	-159.3Cr	-27Cr
Change In Accounts Receivable	-270.3Cr	-297.1Cr	-626Cr	-130.1Cr	-349.8Cr
Change In Inventories	74Cr	-143.5Cr	123.3Cr	-10Cr	-126.7Cr
Change In Accounts Payable	289.8Cr	426Cr	361.8Cr	233.5Cr	385.5Cr
Change in Other Net Operating Assets	301.8Cr	714.9Cr	142.4Cr	-82Cr	-56Cr
Cash from Operations	1.83TCr	1.62TCr	1.34TCr	910.7Cr	1.06TCr
Capital Expenditure	-252Cr	-272.7Cr	-303.1Cr	-278.1Cr	-283.2Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-15Cr	-14Cr	-1.66TCr	-9.5Cr	-44Cr
Divestitures	-	-124.9Cr	-	-	-
Investment in Marketable and Equity Securities, Total	-271.7Cr	-101.7Cr	-131.4Cr	-483.8Cr	-262.9Cr
Other Investing Activities, Total	12Cr	8.5Cr	6.8Cr	10Cr	2.6Cr
Cash from Investing	-526.1Cr	-504.7Cr	-2.09TCr	-761.3Cr	-587.1Cr
Short Term Debt Issued, Total	-	-	520Cr	191.9Cr	-
Long-Term Debt Issued, Total	99Cr	-	1.09TCr	791.3Cr	396.9Cr
Total Debt Issued	99Cr	-	1.61TCr	983.2Cr	396.9Cr
Short Term Debt Repaid, Total	-	-	-500Cr	-	-211.9Cr
Long-Term Debt Repaid, Total	-1.03TCr	-421.1Cr	-316.6Cr	-477.3Cr	-362.9Cr
Total Debt Repaid	-1.03TCr	-421.1Cr	-816.6Cr	-477.3Cr	-574.8Cr
Issuance of Common Stock	55Cr	55Cr	28Cr	36Cr	39Cr
Repurchase of Common Stock	-17Cr	-387Cr	-219.3Cr	-320.8Cr	-16Cr
Common Dividends Paid	-262.5Cr	-290.7Cr	-313.2Cr	-337.3Cr	-339.7Cr
Common & Preferred Stock Dividends Paid	-262.5Cr	-290.7Cr	-313.2Cr	-337.3Cr	-339.7Cr
Other Financing Activities, Total	16Cr	-7.9Cr	-20Cr	2.6Cr	-
Cash from Financing	-1.14TCr	-1.05TCr	268.3Cr	-113.5Cr	-494Cr
Foreign Exchange Rate Adjustments	-	-	-	-	-
Net Change in Cash	164.8Cr	61Cr	-478Cr	36Cr	-17Cr
Supplemental Items
Cash Interest Paid	246.9Cr	223.9Cr	241.8Cr	290.9Cr	299.1Cr
Cash Income Tax Paid (Refund)	319.5Cr	411.6Cr	352.4Cr	170.3Cr	216.6Cr
Levered Free Cash Flow	1.46TCr	1.2TCr	1.11TCr	690.91Cr	592.95Cr
Unlevered Free Cash Flow	1.61TCr	1.35TCr	1.27TCr	875.79Cr	787.89Cr
Change In Net Working Capital	-504.9Cr	-184.8Cr	-201.8Cr	-139Cr	69Cr
Net Debt Issued / Repaid	-926.7Cr	-421.1Cr	793.2Cr	505.9Cr	-177.9Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.71	4.18	3.68	1.99	2.47
Return on Total Capital	5.63	6.57	5.89	3.19	3.99
Return On Equity %	10.89	5.68	11.28	6.02	2.29
Return on Common Equity	10.95	5.68	11.28	6.07	2.35
Margin Analysis
Gross Profit Margin %	17.48	16.62	14.94	13.29	13.29
SG&A Margin	12.74	11.83	10.99	11.12	10.78
EBITDA Margin %	6.29	6.11	5.17	3.4	3.66
EBITA Margin %	5.51	5.36	4.48	2.71	3
EBIT Margin %	4.74	4.79	3.95	2.16	2.51
Income From Continuing Operations Margin %	2.71	1.29	2.35	1.24	0.43
Net Income Margin %	2.72	1.29	2.34	1.24	0.44
Net Avail. For Common Margin %	2.72	1.29	2.34	1.24	0.44
Normalized Net Income Margin	2.68	2.71	2.19	1.22	1.44
Levered Free Cash Flow Margin	5.01	3.74	3.11	1.86	1.48
Unlevered Free Cash Flow Margin	5.55	4.18	3.57	2.36	1.97
Asset Turnover
Asset Turnover	1.25	1.39	1.49	1.47	1.58
Fixed Assets Turnover	8.9	10.25	11.66	12.49	14.03
Receivables Turnover (Average Receivables)	14.34	14.34	16.63	24.52	25.86
Inventory Turnover (Average Inventory)	13.24	14.55	16.35	17.79	18.56
Short Term Liquidity
Current Ratio	0.88	0.94	0.86	0.81	0.84
Quick Ratio	0.55	0.62	0.59	0.56	0.57
Operating Cash Flow to Current Liabilities	0.27	0.23	0.17	0.11	0.12
Days Sales Outstanding (Average Receivables)	25.46	25.46	21.95	14.93	14.12
Days Outstanding Inventory (Average Inventory)	27.56	25.08	22.33	20.57	19.66
Average Days Payable Outstanding	18.06	18.54	17.95	17.53	17.59
Cash Conversion Cycle (Average Days)	34.96	31.99	26.33	17.97	16.19
Long Term Solvency
Total Debt/Equity	100.82	99.18	103.59	109.49	106.06
Total Debt / Total Capital	50.2	49.79	50.88	52.27	51.47
LT Debt/Equity	93.06	94.34	97.44	99.6	98.36
Long-Term Debt / Total Capital	46.34	47.36	47.86	47.54	47.73
Total Liabilities / Total Assets	67.65	68.76	69.31	70.09	70.27
EBIT / Interest Expense	5.5	6.74	5.29	2.71	3.21
EBITDA / Interest Expense	8.59	9.98	8.11	5.29	5.66
(EBITDA - Capex) / Interest Expense	7.58	8.79	6.97	4.35	4.75
Total Debt / EBITDA	3.54	3.1	3.68	5.3	4.53
Net Debt / EBITDA	2.95	2.41	3.15	4.6	3.93
Total Debt / (EBITDA - Capex)	4.01	3.52	4.28	6.45	5.4
Net Debt / (EBITDA - Capex)	3.34	2.74	3.67	5.59	4.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.59	10.56	10.88	3.93	7.87
Gross Profit, 1 Yr. Growth %	5.39	5.13	-0.72	-7.56	7.88
EBITDA, 1 Yr. Growth %	1.02	5.99	-7.65	-31.58	15.92
EBITA, 1 Yr. Growth %	0.2	5.68	-8.84	-37.14	19.42
EBIT, 1 Yr. Growth %	0.83	9.81	-10.6	-43.02	24.94
Earnings From Cont. Operations, 1 Yr. Growth %	9.68	-47.27	93.39	-45.2	-62.32
Net Income, 1 Yr. Growth %	10.18	-47.55	93.55	-44.7	-61.68
Normalized Net Income, 1 Yr. Growth %	8.39	9.31	-12.2	-42.08	26.72
Diluted EPS Before Extra, 1 Yr. Growth %	8.78	-47.23	98.47	-43.43	-62.02
Accounts Receivable, 1 Yr. Growth %	7.66	13.24	-42.73	-6.47	11.66
Inventory, 1 Yr. Growth %	-3.98	7.49	-5.58	0.45	6.29
Net Property, Plant and Equip., 1 Yr. Growth %	-3.95	-3.98	-1.01	-4.92	-3.04
Total Assets, 1 Yr. Growth %	0.99	-2.03	9.4	1.4	0.13
Tangible Book Value, 1 Yr. Growth %	-19.93	-3.58	39.9	-2.29	-16.88
Common Equity, 1 Yr. Growth %	8.19	-5.41	6.98	-1.18	-0.46
Cash From Operations, 1 Yr. Growth %	15.13	-11.43	-17.01	-32.17	16.82
Capital Expenditures, 1 Yr. Growth %	3.41	8.21	11.15	-8.25	1.83
Levered Free Cash Flow, 1 Yr. Growth %	13.21	-18.42	-7.21	-37.62	-14.18
Unlevered Free Cash Flow, 1 Yr. Growth %	9.86	-17.48	-4.7	-31.24	-10.04
Dividend Per Share, 1 Yr. Growth %	0	10	10	9.92	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.65	9.57	10.72	7.35	5.89
Gross Profit, 2 Yr. CAGR %	6.88	5.26	2.29	-4.2	-0.14
EBITDA, 2 Yr. CAGR %	6.29	4.22	-0.55	-20.51	-10.94
EBITA, 2 Yr. CAGR %	6.07	3.74	-1.26	-24.3	-13.36
EBIT, 2 Yr. CAGR %	7.97	6.22	-0.3	-28.63	-15.62
Earnings From Cont. Operations, 2 Yr. CAGR %	9.14	-23.95	2.34	2.95	-54.56
Net Income, 2 Yr. CAGR %	9.19	-23.98	2.12	3.45	-53.97
Normalized Net Income, 2 Yr. CAGR %	12.93	9.99	-1.35	-28.69	-14.33
Diluted EPS Before Extra, 2 Yr. CAGR %	8.22	-24.23	3.67	5.96	-53.65
Accounts Receivable, 2 Yr. CAGR %	10.49	10.41	-13.84	-26.81	2.2
Inventory, 2 Yr. CAGR %	0.69	1.59	0.74	-2.61	3.33
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.36	-3.96	-2.5	-2.98	-3.99
Total Assets, 2 Yr. CAGR %	2.34	-0.53	3.53	5.32	0.76
Tangible Book Value, 2 Yr. CAGR %	-17.85	-12.13	15.4	16.91	-9.88
Common Equity, 2 Yr. CAGR %	8.42	1.16	0.92	2.82	-0.82
Cash From Operations, 2 Yr. CAGR %	19.23	0.98	-14.26	-24.97	-10.98
Capital Expenditures, 2 Yr. CAGR %	1.27	5.78	9.67	0.99	-3.34
Levered Free Cash Flow, 2 Yr. CAGR %	19.67	-3.36	-13.44	-23.92	-26.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	15.62	-4.3	-11.73	-19.05	-21.35
Dividend Per Share, 2 Yr. CAGR %	0	4.88	10	9.96	4.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.48	7.94	10	8.41	7.52
Gross Profit, 3 Yr. CAGR %	18.09	6.29	3.36	-1.11	-0.33
EBITDA, 3 Yr. CAGR %	12.72	6.7	0.61	-12.21	-9.86
EBITA, 3 Yr. CAGR %	13.19	6.51	-0.05	-15.06	-11.88
EBIT, 3 Yr. CAGR %	11.08	9.27	0.99	-17.26	-13.98
Earnings From Cont. Operations, 3 Yr. CAGR %	136.64	-14.36	5.13	-16.89	-26.36
Net Income, 3 Yr. CAGR %	137.03	-14.48	5.14	-16.76	-25.7
Normalized Net Income, 3 Yr. CAGR %	15.56	12.49	2.82	-17.39	-13.62
Diluted EPS Before Extra, 3 Yr. CAGR %	118.31	-14.82	5.76	-15.28	-24.73
Accounts Receivable, 3 Yr. CAGR %	9.4	11.4	-7.19	-11.45	-15.74
Inventory, 3 Yr. CAGR %	2.59	2.91	-0.86	0.65	0.27
Net Property, Plant and Equip., 3 Yr. CAGR %	41.3	-2.24	-2.99	-3.32	-3
Total Assets, 3 Yr. CAGR %	5.85	0.87	2.67	2.81	3.56
Tangible Book Value, 3 Yr. CAGR %	-16.58	-13.34	2.16	9.17	4.35
Common Equity, 3 Yr. CAGR %	8.84	3.6	3.29	0.21	1.72
Cash From Operations, 3 Yr. CAGR %	27.25	7.98	-5.41	-20.7	-13.04
Capital Expenditures, 3 Yr. CAGR %	7.35	3.54	7.54	3.34	1.27
Levered Free Cash Flow, 3 Yr. CAGR %	5.02	5.72	-4.88	-22.4	-20.8
Unlevered Free Cash Flow, 3 Yr. CAGR %	4.31	3.67	-4.64	-18.78	-16.15
Dividend Per Share, 3 Yr. CAGR %	0	3.23	6.56	9.97	6.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.38	11.72	12.96	7.7	8.34
Gross Profit, 5 Yr. CAGR %	11.99	13.4	11.53	2.04	1.95
EBITDA, 5 Yr. CAGR %	6.98	9.93	7.63	-4.86	-4.18
EBITA, 5 Yr. CAGR %	7.12	10.22	7.64	-6.76	-5.6
EBIT, 5 Yr. CAGR %	5.43	9.55	6.96	-7.46	-6.02
Earnings From Cont. Operations, 5 Yr. CAGR %	8.22	-8.88	69.62	-7.11	-24.83
Net Income, 5 Yr. CAGR %	8.27	-8.93	69.64	-7	-24.44
Normalized Net Income, 5 Yr. CAGR %	5.59	9.82	9.12	-5.82	-4.42
Diluted EPS Before Extra, 5 Yr. CAGR %	3.92	-13.41	62.45	-6.35	-23.97
Accounts Receivable, 5 Yr. CAGR %	11.58	12.82	-0.57	-3.25	-3.55
Inventory, 5 Yr. CAGR %	3.77	4.53	1.85	0.67	0.8
Net Property, Plant and Equip., 5 Yr. CAGR %	25.77	24.47	21.81	-2.54	-3.39
Total Assets, 5 Yr. CAGR %	19.79	19.13	4.92	2.62	1.9
Tangible Book Value, 5 Yr. CAGR %	17.24	17.25	-5.02	-2.57	-2.84
Common Equity, 5 Yr. CAGR %	15.31	13.51	5.6	3.42	1.63
Cash From Operations, 5 Yr. CAGR %	12.49	15.1	8.66	-6.65	-7.68
Capital Expenditures, 5 Yr. CAGR %	2.53	7.29	8.27	2.51	3.05
Levered Free Cash Flow, 5 Yr. CAGR %	13.32	15.4	-2.52	-7.45	-14.36
Unlevered Free Cash Flow, 5 Yr. CAGR %	13.75	15.52	-2.18	-6.22	-11.71
Dividend Per Share, 5 Yr. CAGR %	3.3	1.92	3.89	5.87	5.87